Scarica l'app Stockscreener
305.77
0.02%
0.06
Pre-mercato:
305.87
0.10
+0.03%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$305.71
Aprire:
$306.22
Volume 24 ore:
1.64M
Relative Volume:
0.55
Capitalizzazione di mercato:
$164.03B
Reddito:
$33.42B
Utile/perdita netta:
$4.09B
Rapporto P/E:
40.50
EPS:
7.55
Flusso di cassa netto:
$10.39B
1 W Prestazione:
-2.94%
1M Prestazione:
-0.02%
6M Prestazione:
-5.24%
1 anno Prestazione:
+6.80%
Intervallo 1D:
$304.29
$307.57
Intervallo di 1 settimana:
$303.51
$317.58
Portata 52W:
$253.30
$346.85
Amgen Inc Stock (AMGN) Company Profile
Nome
Amgen Inc
Settore
Industria
Telefono
(805)447-1000
Indirizzo
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Confronta AMGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
305.77 | 164.03B | 33.42B | 4.09B | 10.39B | 7.55 |
|
LLY
Lilly Eli Co
|
821.67 | 738.00B | 45.04B | 10.59B | 414.30M | 11.71 |
|
ABBV
Abbvie Inc
|
202.72 | 358.61B | 56.33B | 4.28B | 17.83B | 2.40 |
|
JNJ
Johnson Johnson
|
163.13 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
|
NVO
Novo Nordisk Adr
|
70.16 | 311.44B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
MRK
Merck Co Inc
|
87.60 | 221.28B | 64.17B | 17.12B | 18.10B | 6.73 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-10 | Ripresa | BofA Securities | Underperform |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-14 | Iniziato | Citigroup | Neutral |
| 2024-10-17 | Iniziato | Bernstein | Outperform |
| 2024-10-14 | Downgrade | Truist | Buy → Hold |
| 2024-09-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Ripresa | Raymond James | Mkt Perform |
| 2024-02-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-11-02 | Aggiornamento | Truist | Hold → Buy |
| 2023-10-20 | Ripresa | JP Morgan | Neutral |
| 2023-10-17 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Ripresa | BofA Securities | Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-04-24 | Reiterato | Oppenheimer | Outperform |
| 2023-03-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Reiterato | Truist | Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Underperform |
| 2022-10-31 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Iniziato | SVB Leerink | Mkt Perform |
| 2022-02-09 | Reiterato | Barclays | Equal Weight |
| 2022-02-09 | Reiterato | Jefferies | Buy |
| 2022-02-09 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Reiterato | Oppenheimer | Outperform |
| 2022-02-09 | Reiterato | Wells Fargo | Equal Weight |
| 2022-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-12-09 | Ripresa | Wells Fargo | Equal Weight |
| 2021-12-06 | Iniziato | Goldman | Buy |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-09-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Iniziato | Daiwa Securities | Buy |
| 2020-10-28 | Iniziato | UBS | Neutral |
| 2020-10-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Aggiornamento | Truist | Hold → Buy |
| 2020-10-09 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Downgrade | Truist | Buy → Hold |
| 2020-10-08 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Ripresa | Guggenheim | Neutral |
| 2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
| 2020-03-30 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Iniziato | Barclays | Equal Weight |
| 2020-01-31 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-17 | Ripresa | Morgan Stanley | Overweight |
| 2019-11-12 | Iniziato | SunTrust | Buy |
| 2019-11-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-19 | Downgrade | Mizuho | Buy → Neutral |
| 2019-05-23 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Amgen Inc Borsa (AMGN) Ultime notizie
Modern Wealth Management LLC Boosts Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
How To Trade (AMGN) - Stock Traders Daily
Knights of Columbus Asset Advisors LLC Has $31,000 Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Crowley Wealth Management Inc. Invests $2.61 Million in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Vanguard Group Inc. Has $13.74 Billion Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
AXQ Capital LP Purchases New Shares in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Stevens Capital Management LP Buys Shares of 6,849 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Prudential Financial Inc. Sells 29,757 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
US biopharmaceutical firms with foreign exposure face disruption as Trump’s tariffs loom - Proactive Investors USA
Trump Weighs Tariffs on Ireland’s Pharma Industry. How to Play the Sector. - Barron's
Fresenius Kabi Reached A Global Settlement With Amgen Concerning Their Denosumab Biosimilars - Marketscreener.com
How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology - PharmaVoice
UNIVEST FINANCIAL Corp Has $3.70 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Ipsen Advisor Group LLC Invests $549,000 in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Morey & Quinn Wealth Partners LLC Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Trims Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
PKS Advisory Services LLC Takes $410,000 Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
TD Asset Management Inc. Sells 43,508 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Samalin Investment Counsel LLC Has $826,000 Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
HUB Investment Partners LLC Sells 1,017 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Sei Investments Co. Sells 89,525 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Is the Market Bullish or Bearish on Amgen? - Benzinga
Fresenius biosimilars cleared to target Amgen's Prolia (FMS) - Seeking Alpha
Aire Advisors LLC Grows Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
CoreFirst Bank & Trust Makes New $585,000 Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Princeton Capital Management LLC Decreases Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
EntryPoint Capital LLC Purchases New Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Madison Investment Advisors LLC Invests $1.95 Million in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Royal London Asset Management Ltd. - MarketBeat
3,149 Shares in Amgen Inc. (NASDAQ:AMGN) Bought by Antonelli Financial Advisors LLC - MarketBeat
Holderness Investments Co. Acquires 928 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
DCF Advisers LLC Decreases Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Biotech Stocks Slide Due to Tariff Concerns (AMGN) - GuruFocus.com
Gutierrez Wealth Advisory LLC Makes New Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) is Sector Gamma AS's 9th Largest Position - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Buys New Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Why Pharma and Biotech Stocks Got Thrashed on Tuesday - The Motley Fool
Amgen Options Trading: A Deep Dive into Market Sentiment - Benzinga
Amgen Inc. (NASDAQ:AMGN) Stake Lowered by Corebridge Financial Inc. - MarketBeat
Analysts Set Amgen Inc. (NASDAQ:AMGN) Target Price at $314.04 - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Teacher Retirement System of Texas - MarketBeat
Amgen Wants $50M Leukemia Drug Patent Verdict Thrown Out - Law360
Amgen (AMGN) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Amgen Seeks to Toss $50 Million Blincyto Loss on Lindis Patents - Bloomberg Law
Emerald Advisers LLC Trims Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Congress Wealth Management LLC DE Has $19.02 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Napatree Capital LLC Buys 1,059 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
iA Global Asset Management Inc. Has $15.10 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Stokes Family Office LLC Buys 2,218 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
ProVise Management Group LLC Cuts Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Harvest Fund Management Co. Ltd Grows Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc Azioni (AMGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.79%
1.73%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):